Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Nouryon to acquire ADOB Fertilizers

Nouryon has entered into a definitive agreement to acquire ADOB Fertilizers, a supplier of chelated micronutrients, foliars, and other specialty fertilizers. The acquisition will enable Nouryon to expand its product portfolio and broaden its offerings for customers in the crop nutrition market.

“The addition of the ADOB business to Nouryon’s portfolio is an excellent strategic opportunity for our company,” said Charlie Shaver, Chairman, and CEO of Nouryon. “This transaction confirms our commitment to our customers in the Agriculture and Food industry. We look forward to welcoming the employees and customers of ADOB to the Nouryon family.”

Headquartered in Poznań, Poland, ADOB is a provider of water-soluble fertilizers and micronutrients and has been producing specialty solutions for agricultural and horticultural crops for more than 30 years.

“With its strong focus on technology and innovation, including biodegradable micronutrients, high-solubility specialty fertilizers, and custom formulations, ADOB’s capabilities are an excellent complement to Nouryon’s existing capabilities in crop nutrition,” said Larry Ryan, Executive Vice President and President of Performance Formulations and the Americas at Nouryon.

“This combination is a great opportunity for ADOB to leverage a large global organization to advance to the next stage of global growth,” said Adam Nawrocki, owner, and CEO of ADOB. “I look forward to supporting the combined company on this journey in the coming months.”

The transaction is expected to close by year-end 2022, subject to required approvals and customary closing conditions. Additional terms of the agreement were not disclosed.

For more information:

Publication date: